Medical Superconducting Magnet Research:CAGR of 4.8% during the forecast period

QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Medical Superconducting Magnet- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Medical Superconducting Magnet market, including market size, share, demand, industry development status, and forecasts for the next few years.

The global market for Medical Superconducting Magnet was estimated to be worth US$ 1189 million in 2025 and is projected to reach US$ 1640 million, growing at a CAGR of 4.8% from 2026 to 2032.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5737797/medical-superconducting-magnet

Medical Superconducting Magnet Market Summary

Medical superconducting magnets are core main-field components used in medical magnetic resonance imaging systems. They typically consist of superconducting coils, cryogenic cooling systems, vacuum cryostats, magnetic shielding structures, shimming components, mechanical supports, and monitoring or control units. These magnets generate highly uniform and stable static magnetic fields for clinical diagnosis and medical research. The market mainly covers 1.5T and 3.0T whole-body MRI magnets, selected 0.5T-1.2T open or low-field superconducting systems, and emerging 5.0T and 7.0T ultra-high-field medical research systems. Key performance parameters include field strength, bore size, homogeneity, temporal stability, helium consumption, cooling architecture, weight, fringe-field control, and installation requirements.

According to the new market research report "Global Medical Superconducting Magnet Market Report 2026-2032", published by QYResearch, the global Medical Superconducting Magnet market size is projected to reach USD 1.64 billion by 2032, at a CAGR of 4.8% during the forecast period.

Figure00001. Global Medical Superconducting Magnet Market Size (US$ Million), 2021-2032

Medical Superconducting Magnet

Above data is based on report from QYResearch: Global Medical Superconducting Magnet Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

Medical superconducting magnets should not be viewed as ordinary components inside MRI systems. They are platform-level core parts that determine imaging capability, operational stability, installation cost, lifecycle service value, and the upgrade potential of the entire MRI system. Global access to MRI remains uneven, and both the OECD and WHO use MRI units per million population as an important indicator of diagnostic imaging availability. This means demand for superconducting magnets comes not only from new hospital purchases, but also from replacement of installed equipment, regional healthcare capacity upgrades, and the shift of advanced medical centers toward higher field strength and higher workflow efficiency. At the market level, demand elasticity is not driven only by annual hospital capital expenditure. It is more closely linked to long-term healthcare investment in early screening, neurological disorders, oncology, cardiovascular disease, musculoskeletal imaging, and research-oriented imaging. China's policy framework encouraging the renewal of medical imaging, radiotherapy, remote diagnosis and treatment, and other healthcare equipment also provides medium- to long-term support for high-end MRI systems and their upstream superconducting magnet supply chain.

On the supply side, the technical threshold of this industry is far higher than that of general medical device components. A medical superconducting magnet integrates superconducting materials, cryogenic engineering, vacuum insulation, magnetic field homogeneity, quench protection, mechanical structure, shielding design, installation, commissioning, and long-term maintenance. It must also be optimized together with gradient systems, RF coils, spectrometers, AI reconstruction, and clinical software. United Imaging's annual report identifies superconducting magnet technology, gradient technology, RF technology, spectrometer design, and application technology as key technical barriers in MRI, and states that the company has developed zero-liquid-helium, 1.5T, 3.0T, 5.0T, and higher-field superconducting magnet capabilities. Therefore, suppliers with real industrial value are not those that can merely produce magnet housings or cryogenic parts. They are companies capable of delivering clinical-grade field performance, passing system-level regulatory validation, achieving stable batch manufacturing, and assuming long-term service responsibility. For MRI OEMs, magnet supply security directly affects product iteration, delivery cycles, and global expansion. For independent magnet suppliers, long customer qualification cycles, strict quality traceability, and high switching costs create strong customer stickiness and entry barriers.

Technologically, the industry is moving from a simple pursuit of higher field strength toward integrated competition in high field strength, low helium usage, lower energy consumption, wider bore design, and intelligent system collaboration. 1.5T remains the clinical installed-base foundation worldwide, 3.0T is the main upgrade path for advanced clinical and research applications, while 5.0T and higher-field systems represent the technological frontier and future translational potential. At the same time, helium supply risk and operating cost are reshaping hospital procurement decisions. The USGS notes that helium has no full substitute in cryogenic applications requiring extremely low temperatures, while superconductors including those used in MRI are being developed to operate at higher temperatures and potentially use alternative cooling routes such as nitrogen. This makes zero-boil-off, low-helium, and helium-free magnet platforms increasingly important. Leading global OEMs have already commercialized this direction: Siemens Healthineers received FDA clearance in 2026 for a 70 cm 1.5T MRI platform using DryCool virtually helium-free technology; GE HealthCare disclosed new MR products including SIGNA Sprint with Freelium 1.5T; and Philips introduced a BlueSeal helium-free 3.0T platform, while reporting more than 2,000 installations of its 1.5T BlueSeal systems. These developments show that magnet technology has shifted from a hidden hardware capability to a visible product differentiator.

In terms of competition, the medical superconducting magnet industry is shaped by a hybrid structure: vertical integration by major MRI OEMs, specialized core component suppliers, and regional localization. Global MRI leaders usually control magnet design, system integration, and customer access, enabling magnet upgrades through complete MRI platforms. Independent magnet manufacturers compete through engineering execution, manufacturing yield, cost control, and customer certification, often gaining positions in specific field-strength ranges, platforms, or regional supply chains. China is an especially important market to watch. High-end medical imaging equipment is still constrained by regulatory approval, clinical validation, brand credibility, and service networks. However, policy support, hospital replacement demand, breakthroughs by domestic MRI OEMs, and the maturing local core component supply chain are pushing superconducting magnets from import-dependent components toward scalable domestic strategic parts. NMPA rules emphasize safety, effectiveness, quality control, and lifecycle responsibility for medical devices, which means competition will increasingly depend on quality systems, batch stability, and clinical traceability rather than price alone.

Overall, the medical superconducting magnet market is not a purely high-speed, homogeneous expansion market. It is a structural upgrade market. Primary and county-level healthcare demand supports broader access to 1.5T systems; tertiary hospitals and specialty centers drive replacement toward 3.0T and higher-end platforms; and research institutions and advanced clinical centers create demand for ultra-high-field, animal research, and multimodal imaging systems. A credible industry report should therefore go beyond MRI shipment volume. It should analyze field-strength mix, magnet technology routes, helium consumption models, OEM self-supply versus external procurement, customer structures of independent suppliers, regional regulatory barriers, service models, and total lifecycle operating cost. Only by connecting the magnet, MRI system, hospital, clinical use case, and operating economics in one analytical framework can the true growth drivers, competitive barriers, and localization opportunities of this industry be accurately assessed.

Figure00002. Global Medical Superconducting Magnet Top 9 Players Ranking and Market Share (Ranking is based on the revenue of 2025, by revenue, continually updated)

Medical Superconducting Magnet

Above data is based on report from QYResearch: Global Medical Superconducting Magnet Market Report 2026-2032 (published in 2026). If you need the latest data, plaese contact QYResearch.

According to QYResearch Top Players Research Center, the global key manufacturers of Medical Superconducting Magnet include Siemens Healthineers, GE Healthcare, Philips, Shanghai United Imaging Medical Technology, Ningbo Jansen NMR Technology, etc. In 2025, the global top five players had a share approximately 93.0% in terms of revenue.

Major Players Profiles:

Figure00003. Production Process Flowchart for Medical Superconducting Magnet

Medical Superconducting Magnet

Source: QYResearch: Global Medical Superconducting Magnet Market Report 2026-2032 (published in 2026).

The production process of a medical superconducting magnet generally consists of four key stages: winding, wiring, assembly, and testing. The process begins with the winding stage, where the main coil is insulated and wound according to the required magnetic field design. The shielding coil is then insulated and wound to reduce stray magnetic fields and improve system safety and field control. The quality of coil winding has a direct impact on magnetic field uniformity, operational stability, and long-term reliability, making it one of the most critical steps in the entire manufacturing process.

The wiring stage includes coil lead connection, protection circuit wiring, terminal or joint fabrication, and insulation testing. This stage affects both current transmission efficiency and quench protection safety. In the assembly stage, the 4K cold mass vessel, 50K thermal shield, and 300K vacuum vessel are assembled in sequence, followed by welding of key structural components to form the cryogenic and thermal insulation system. The final testing stage includes vacuum pumping, cooling, magnet energization, field shimming, and comprehensive performance testing. These procedures verify vacuum integrity, cryogenic stability, magnetic field strength, field uniformity, and overall safety. Only magnets that pass strict testing can proceed to MRI system integration and clinical use.

Figure00004. Medical Superconducting Magnet Industry Chain

Medical Superconducting Magnet

Medical Superconducting Magnet

Medical Superconducting Magnet

The medical superconducting magnet industry chain can be divided into three major segments: upstream raw materials and core components, midstream magnet design and manufacturing, and downstream MRI systems and end-use applications. The upstream segment mainly includes superconducting wire, liquid helium, cryocoolers, cryogenic insulation materials, electrical insulation materials, structural parts, dewars, cold shields, current leads, vacuum components, sensors, power supply systems, and quench protection systems. Among these, superconducting wire, liquid helium, and cryocoolers are the key factors affecting magnet performance, operating cost, and supply stability. The midstream segment is the core of the value chain, covering magnetic field design, electromagnetic simulation, structural design, cryogenic thermal design, coil winding, insulation treatment, wiring, cold shield assembly, dewar integration, vacuum sealing, welding, cooling, excitation, shimming, and reliability testing. These processes require high manufacturing precision, strong cryogenic engineering capability, strict quality control, and system integration expertise. Downstream, MRI equipment manufacturers integrate superconducting magnets with gradient systems, RF systems, spectrometers, software, and clinical platforms to produce 1.5T, 3.0T, and higher-field MRI systems. These systems are mainly used in general hospitals, specialty hospitals, imaging centers, research institutions, and high-end health examination facilities. Overall, the industry chain is long, technology-intensive, and characterized by lengthy validation cycles, with core competitiveness concentrated in cryogenic superconducting technology, magnetic field homogeneity control, low-helium or helium-free solutions, quench protection, stable mass production, and system-level integration.

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The Medical Superconducting Magnet market is segmented as below:
By Company
Siemens Healthineers
GE Healthcare
Philips
Shanghai United Imaging Medical Technology
Ningbo Jansen NMR Technology
JASTEC
Bruker
Tesla Engineering
ASG Superconductors
Shanghai Chenguang Medical Technologies
Weifang Xinli Superconducting Magnet
Neusoft Medical Systems

Segment by Type
1.5T
3.0T
Others

Segment by Application
Clinical Application
Scientific Research Application

Each chapter of the report provides detailed information for readers to further understand the Medical Superconducting Magnet market:

Chapter 1: Introduces the report scope of the Medical Superconducting Magnet report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. (2021-2032)
Chapter 2: Detailed analysis of Medical Superconducting Magnet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. (2021-2026)
Chapter 3: Provides the analysis of various Medical Superconducting Magnet market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. (2021-2032)
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.(2021-2032)
Chapter 5: Sales, revenue of Medical Superconducting Magnet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world..(2021-2032)
Chapter 6: Sales, revenue of Medical Superconducting Magnet in country level. It provides sigmate data by Type, and by Application for each country/region.(2021-2032)
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. (2021-2026)
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Benefits of purchasing QYResearch report:

Competitive Analysis: QYResearch provides in-depth Medical Superconducting Magnet competitive analysis, including information on key company profiles, new entrants, acquisitions, mergers, large market shear, opportunities, and challenges. These analyses provide clients with a comprehensive understanding of market conditions and competitive dynamics, enabling them to develop effective market strategies and maintain their competitive edge.

Industry Analysis: QYResearch provides Medical Superconducting Magnet comprehensive industry data and trend analysis, including raw material analysis, market application analysis, product type analysis, market demand analysis, market supply analysis, downstream market analysis, and supply chain analysis.

and trend analysis. These analyses help clients understand the direction of industry development and make informed business decisions.

Market Size: QYResearch provides Medical Superconducting Magnet market size analysis, including capacity, production, sales, production value, price, cost, and profit analysis. This data helps clients understand market size and development potential, and is an important reference for business development.

Other relevant reports of QYResearch:
Global Medical Superconducting Magnet Market Outlook, In‐Depth Analysis & Forecast to 2032
Global Medical Superconducting Magnet Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
Global Medical Superconducting Magnet Market Research Report 2026

Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
Email: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp

About Us:
QYResearch founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 19 years of experience and a dedicated research team, we are well placed to provide useful information and data for your business, and we have established offices in 7 countries (include United States, Germany, Switzerland, Japan, Korea, China and India) and business partners in over 30 countries. We have provided industrial information services to more than 60,000 companies in over the world.

This release was published on openPR.